Endocrinology & Metabolism Clinical Trials

Statistical methods in endocrinology & metabolism trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All endocrinology & metabolism trials

1,009 results

• HARMONIZE GLIndependent statistical analysis of A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 267NCT02875834
• Health Effects of Increasing Muscle Activation While Sitting in Office Workers: Complete Statistical AnalysisIndependent statistical analysis of Health Effects of Increasing Muscle Activation While Sitting in Office Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 25NCT02855541
• Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D): Complete Statistical AnalysisIndependent statistical analysis of Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 217NCT05413239
• HEALTHY BITESIndependent statistical analysis of Helping Educate and Advance Learning Through Healthy Bite-Sized Eating Strategies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06082830).Phase NAResults postedn = 15NCT06082830
• Healthy Body, Healthy Bones After Bariatric Surgery Trial: Complete Statistical AnalysisIndependent statistical analysis of Healthy Body, Healthy Bones After Bariatric Surgery Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04279392).Phase 1/2Results postedn = 10NCT04279392
• HEART-FIDIndependent statistical analysis of Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 3,065NCT03037931
• HEIRitageIndependent statistical analysis of Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05530356).Phase NAResults postedn = 57NCT05530356
• Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis: Complete Statistical AnalysisIndependent statistical analysis of Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654549).Phase 2Results postedn = 40NCT01654549
• Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine: Complete Statistical AnalysisIndependent statistical analysis of Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine: primary endpoint results, effect estimate…Phase NAResults postedn = 21NCT00595127
• HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism: Complete Statistical AnalysisIndependent statistical analysis of HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01199614).Phase 3Results postedn = 62NCT01199614
• High Dose or High Dose Frequency Study of Alglucosidase Alfa: Complete Statistical AnalysisIndependent statistical analysis of High Dose or High Dose Frequency Study of Alglucosidase Alfa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00483379).Phase 4Results postedn = 13NCT00483379
• High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 28NCT06470087
• HIP: Hip Imaging Protocol: Complete Statistical AnalysisIndependent statistical analysis of HIP: Hip Imaging Protocol: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126161).Phase NAResults postedn = 18NCT04126161
• HiRTIndependent statistical analysis of Hyperglycemia in Renal Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643382).Phase NAResults postedn = 60NCT01643382
• Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON): Complete Statistical AnalysisIndependent statistical analysis of Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 219NCT02796274
• HPV Vaccine Intervention for Young Sexual Minority Men: Complete Statistical AnalysisIndependent statistical analysis of HPV Vaccine Intervention for Young Sexual Minority Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04032106).Phase NAResults postedn = 1,227NCT04032106
• HSCT for High Risk Inherited Inborn Errors: Complete Statistical AnalysisIndependent statistical analysis of HSCT for High Risk Inherited Inborn Errors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383448).Phase 2Results postedn = 38NCT00383448
• Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 1/2Results postedn = 10NCT00547365
• Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02463097).Phase NAResults postedn = 124NCT02463097
• Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Versus Pioglitazone in Combination Treatment for Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 22NCT02303405
• HypoANSIndependent statistical analysis of Hypoglycemia and Autonomic Nervous System Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01816893).Phase NAResults postedn = 22NCT01816893
• Hypothyroidism Treated With Calcitonin: Complete Statistical AnalysisIndependent statistical analysis of Hypothyroidism Treated With Calcitonin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03342001).Phase 4Results postedn = 11NCT03342001
• IDNTAn independent statistical analysis and educational interpretation of IDNT (NCT00021918), an ancillary study of serum total homocysteine and C-reactive protein in cardiovascular and related metabolic conditions.NCT00021918
• IGF-1 and Bone Loss in Women With Anorexia Nervosa: Complete Statistical AnalysisIndependent statistical analysis of IGF-1 and Bone Loss in Women With Anorexia Nervosa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01406444).Phase NAResults postedn = 148NCT01406444
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): Complete Statistical AnalysisIndependent statistical analysis of iGlarLixi vs IDegAsp in Chinese Participants After OAD(s): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05413369).Phase 3Results postedn = 582NCT05413369
• ILLUMINATEIndependent statistical analysis of the ILLUMINATE phase 3 trial of torcetrapib/atorvastatin versus atorvastatin in patients with coronary disease and diabetes mellitus, including trial design, the primary cardiovascular endpoint, planned time-to-event analysis, and…Phase 3n = 15,067NCT00134264
• IMAGINE 2Independent statistical analysis of A Study in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435616).Phase 3Results postedn = 1,538NCT01435616
• IMAGINE 8Independent statistical analysis of A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence…Phase 3Results postedn = 68NCT02132637
• Immersive Virtual Reality Bicycling for Persons With Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05160025).Phase NAResults postedn = 22NCT05160025
• Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: Complete Statistical AnalysisIndependent statistical analysis of Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 62NCT04283773
• IMOVAIndependent statistical analysis of Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 11NCT02792959
• IMPACTIndependent statistical analysis of An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 328NCT02232698
• Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With T2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 96NCT02488785
• Impact of COVID-19 on Marshallese Communities in the U.S.: Complete Statistical AnalysisIndependent statistical analysis of Impact of COVID-19 on Marshallese Communities in the U.S.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04474496).Phase NAResults postedn = 120NCT04474496
• Impact of LDL-cholesterol Lowering on Platelet Activation: Complete Statistical AnalysisIndependent statistical analysis of Impact of LDL-cholesterol Lowering on Platelet Activation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03331666).Phase 4Results postedn = 4NCT03331666
• Impact of Liraglutide 3.0 on Body Fat Distribution: Complete Statistical AnalysisIndependent statistical analysis of Impact of Liraglutide 3.0 on Body Fat Distribution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03038620).Phase 4Results postedn = 235NCT03038620
• Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Impact of Meal Timing on Glycemic Profile in Latino Adolescents With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 22NCT05391438
• Impact of Sleep Restriction on Performance in Adults: Complete Statistical AnalysisIndependent statistical analysis of Impact of Sleep Restriction on Performance in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02960776).Phase NAResults postedn = 45NCT02960776
• Implementation and Evaluation of a Before School Physical Activity Program in Revere, MA: Complete Statistical AnalysisIndependent statistical analysis of Implementation and Evaluation of a Before School Physical Activity Program in Revere, MA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 188NCT03805295
• Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 1,910NCT05265312
• Implementing HEARTS in Guatemala: Complete Statistical AnalysisIndependent statistical analysis of Implementing HEARTS in Guatemala: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06080451).Phase NAResults postedn = 964NCT06080451
• Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone: Complete Statistical AnalysisIndependent statistical analysis of Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 24NCT00538642
• Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02409329).Phase NAResults postedn = 512NCT02409329
• Improving Medication Adherence in the Alabama Black Belt: Complete Statistical AnalysisIndependent statistical analysis of Improving Medication Adherence in the Alabama Black Belt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02274844).Phase NAResults postedn = 473NCT02274844
• Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: Complete Statistical AnalysisIndependent statistical analysis of Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05734989).Phase NAResults postedn = 248NCT05734989
• IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase: Complete Statistical AnalysisIndependent statistical analysis of IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 4NCT04028960
• In-home Obesity Prevention to Reach Low-income Infants: Complete Statistical AnalysisIndependent statistical analysis of In-home Obesity Prevention to Reach Low-income Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03529695).Phase NAResults postedn = 77NCT03529695
• In-Home Technology for Dementia Caregivers: Complete Statistical AnalysisIndependent statistical analysis of In-Home Technology for Dementia Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03828383).Phase NAResults postedn = 78NCT03828383
• Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia: Complete Statistical AnalysisIndependent statistical analysis of Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 123NCT03238911
• Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 30NCT03010137

← All therapeutic areas